The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AbCellera Biologics Inc. | COM | 00288U106 | 259,145,283 | 33,012,138 | SH | SOLE | 33,012,138 | 0 | 0 | ||
| Absci Corporation | COM | 00091E109 | 24,742,367 | 2,134,803 | SH | SOLE | 2,134,803 | 0 | 0 | ||
| ACADIA Pharmaceuticals Inc. | COM | 004225108 | 1,085,696,471 | 42,912,904 | SH | SOLE | 42,912,904 | 0 | 0 | ||
| Aktis Oncology, Inc. | COM | 01021M104 | 32,112,393 | 996,351 | SH | SOLE | 996,351 | 0 | 0 | ||
| Aligos Therapeutics, Inc. | COM | 01626L204 | 479,227 | 83,055 | SH | SOLE | 83,055 | 0 | 0 | ||
| Alkermes plc | SHS | G01767105 | 524,592,729 | 10,012,267 | SH | SOLE | 10,012,267 | 0 | 0 | ||
| Alumis Inc. | COM | 022307102 | 56,631,750 | 2,012,500 | SH | SOLE | 2,012,500 | 0 | 0 | ||
| Arcus Biosciences, Inc. | COM | 03969F109 | 26,045,677 | 844,816 | SH | SOLE | 844,816 | 0 | 0 | ||
| Arrowhead Pharmaceuticals, Inc. | COM | 04280A100 | 162,431,742 | 1,992,783 | SH | SOLE | 1,992,783 | 0 | 0 | ||
| Avalo Therapeutics, Inc. | COM | 05338F306 | 10,164,000 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
| Avalyn Pharma Inc. | COM SHS | 05348Y105 | 11,522,000 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| BeOne Medicines Ltd. | SPONSORED ADS | 07725L102 | 2,508,182,548 | 8,801,567 | SH | SOLE | 8,801,567 | 0 | 0 | ||
| Bicycle Therapeutics plc | SPONSORED ADS | 088786108 | 46,153,914 | 10,885,357 | SH | SOLE | 10,885,357 | 0 | 0 | ||
| BioNTech SE | SPONSORED ADS | 09075V102 | 11,142,086 | 119,743 | SH | SOLE | 119,743 | 0 | 0 | ||
| Celcuity Inc. | COM | 15102K100 | 828,150,159 | 7,915,792 | SH | SOLE | 7,915,792 | 0 | 0 | ||
| Celldex Therapeutics, Inc. | COM | 15117B202 | 44,004,955 | 1,182,611 | SH | SOLE | 1,182,611 | 0 | 0 | ||
| Cerus Corporation | COM | 157085101 | 18,674,659 | 6,395,431 | SH | SOLE | 6,395,431 | 0 | 0 | ||
| Crinetics Pharmaceuticals, Inc. | COM | 22663K107 | 87,991,820 | 2,351,465 | SH | SOLE | 2,351,465 | 0 | 0 | ||
| Cytokinetics, Incorporated | COM | 23282W605 | 17,997,836 | 211,267 | SH | SOLE | 211,267 | 0 | 0 | ||
| CytomX Therapeutics, Inc. | COM | 23284F105 | 18,659,348 | 4,975,826 | SH | SOLE | 4,975,826 | 0 | 0 | ||
| DBV Technologies S.A. | SPONSORED ADS | 23306J309 | 23,967,370 | 1,461,425 | SH | SOLE | 1,461,425 | 0 | 0 | ||
| Denali Therapeutics Inc. | COM | 24823R105 | 96,047,122 | 3,734,336 | SH | SOLE | 3,734,336 | 0 | 0 | ||
| Design Therapeutics, Inc. | COM | 25056L103 | 38,756,882 | 2,678,430 | SH | SOLE | 2,678,430 | 0 | 0 | ||
| Dianthus Therapeutics, Inc. | COM | 252828108 | 83,068,947 | 852,164 | SH | SOLE | 852,164 | 0 | 0 | ||
| Disc Medicine, Inc. | COM | 254604101 | 25,573,913 | 349,657 | SH | SOLE | 349,657 | 0 | 0 | ||
| Dyne Therapeutics, Inc. | COM | 26818M108 | 18,066,702 | 813,449 | SH | SOLE | 813,449 | 0 | 0 | ||
| Edgewise Therapeutics, Inc. | COM | 28036F105 | 150,400,843 | 3,701,719 | SH | SOLE | 3,701,719 | 0 | 0 | ||
| Eikon Therapeutics, Inc. | COM | 282564103 | 7,249,993 | 555,555 | SH | SOLE | 555,555 | 0 | 0 | ||
| Enliven Therapeutics, Inc. | COM | 29337E102 | 45,938,443 | 905,191 | SH | SOLE | 905,191 | 0 | 0 | ||
| Entrada Therapeutics, Inc. | COM | 29384C108 | 37,335,293 | 5,072,730 | SH | SOLE | 5,072,730 | 0 | 0 | ||
| Evommune, Inc. | COM SHS | 30054Y107 | 11,261,813 | 847,390 | SH | SOLE | 847,390 | 0 | 0 | ||
| Faeth Therapeutics, Inc. | COM | 81728A207 | 32,160,275 | 1,286,411 | SH | SOLE | 1,286,411 | 0 | 0 | ||
| Generate Biomedicines, Inc. | COM SHS | 370920100 | 24,016,166 | 1,423,602 | SH | SOLE | 1,423,602 | 0 | 0 | ||
| GRAIL, Inc. | COM | 384747101 | 275,033,478 | 4,028,614 | SH | SOLE | 4,028,614 | 0 | 0 | ||
| IDEAYA Biosciences, Inc. | COM | 45166A102 | 186,723,818 | 5,010,030 | SH | SOLE | 5,010,030 | 0 | 0 | ||
| Immatics N.V. | SHS | N44445109 | 96,321,763 | 9,508,565 | SH | SOLE | 9,508,565 | 0 | 0 | ||
| Immunome, Inc. | COM | 45257U108 | 1,171,934 | 55,306 | SH | SOLE | 55,306 | 0 | 0 | ||
| Immunovant, Inc. | COM | 45258J102 | 209,419,027 | 5,435,220 | SH | SOLE | 5,435,220 | 0 | 0 | ||
| Incyte Corporation | COM | 45337C102 | 3,487,217,729 | 30,762,330 | SH | SOLE | 30,762,330 | 0 | 0 | ||
| Insmed Incorporated | COM PAR $.01 | 457669307 | 937,841,355 | 8,796,111 | SH | SOLE | 8,796,111 | 0 | 0 | ||
| Intellia Therapeutics, Inc. | COM | 45826J105 | 15,739,525 | 930,232 | SH | SOLE | 930,232 | 0 | 0 | ||
| Ionis Pharmaceuticals, Inc. | COM | 462222100 | 162,364,274 | 2,047,727 | SH | SOLE | 2,047,727 | 0 | 0 | ||
| Jade Biosciences, Inc. | COM | 008064206 | 27,340,066 | 1,230,426 | SH | SOLE | 1,230,426 | 0 | 0 | ||
| Kiniksa Pharmaceuticals International, plc | ORD SHS CL A | G52694109 | 181,275,420 | 2,834,643 | SH | SOLE | 2,834,643 | 0 | 0 | ||
| Kodiak Sciences Inc. | COM | 50015M109 | 776,051,487 | 19,919,186 | SH | SOLE | 19,919,186 | 0 | 0 | ||
| Kymera Therapeutics, Inc. | COM | 501575104 | 992,725,940 | 8,657,242 | SH | SOLE | 8,657,242 | 0 | 0 | ||
| LB Pharmaceuticals Inc. | COM SHS | 50180M108 | 6,491,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| Madrigal Pharmaceuticals, Inc. | COM | 558868105 | 1,150,754,190 | 2,143,131 | SH | SOLE | 2,143,131 | 0 | 0 | ||
| MapLight Therapeutics, Inc. | COM | 56565P103 | 13,071,027 | 364,705 | SH | SOLE | 364,705 | 0 | 0 | ||
| Mirum Pharmaceuticals, Inc. | COM | 604749101 | 52,210,293 | 445,975 | SH | SOLE | 445,975 | 0 | 0 | ||
| Monte Rosa Therapeutics, Inc. | COM | 61225M102 | 105,166,811 | 4,345,736 | SH | SOLE | 4,345,736 | 0 | 0 | ||
| Neurogene Inc. | COM | 64135M105 | 31,188,682 | 991,691 | SH | SOLE | 991,691 | 0 | 0 | ||
| Nurix Therapeutics, Inc. | COM | 67080M103 | 113,016,569 | 4,658,556 | SH | SOLE | 4,658,556 | 0 | 0 | ||
| Parabilis Medicines, Inc. | COM | 698955101 | 13,685,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| Praxis Precision Medicines, Inc. | COM | 74006W207 | 586,953,158 | 1,753,198 | SH | SOLE | 1,753,198 | 0 | 0 | ||
| Prelude Therapeutics Inc. | COM | 74065P101 | 53,959,982 | 10,123,824 | SH | SOLE | 10,123,824 | 0 | 0 | ||
| Protara Therapeutics, Inc. | COM STK | 74365U107 | 3,711,565 | 971,614 | SH | SOLE | 971,614 | 0 | 0 | ||
| Rapport Therapeutics, Inc. | COM | 75383L102 | 64,467,240 | 1,547,090 | SH | SOLE | 1,547,090 | 0 | 0 | ||
| Relay Therapeutics, Inc. | COM | 75943R102 | 52,889,110 | 2,826,783 | SH | SOLE | 2,826,783 | 0 | 0 | ||
| Replimune Group, Inc. | COM | 76029N106 | 122,271,870 | 11,045,336 | SH | SOLE | 11,045,336 | 0 | 0 | ||
| Revolution Medicines, Inc. | COM | 76155X100 | 2,143,111,899 | 11,443,357 | SH | SOLE | 11,443,357 | 0 | 0 | ||
| Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | 622,265,747 | 5,604,483 | SH | SOLE | 5,604,483 | 0 | 0 | ||
| Roivant Sciences Ltd. | SHS | G76279101 | 166,928,649 | 4,716,831 | SH | SOLE | 4,716,831 | 0 | 0 | ||
| Sagimet Biosciences Inc. | COM SER A | 786700104 | 7,366,659 | 952,996 | SH | SOLE | 952,996 | 0 | 0 | ||
| Sana Biotechnology, Inc. | COM | 799566104 | 1,083,586 | 310,483 | SH | SOLE | 310,483 | 0 | 0 | ||
| Sera Prognostics, Inc. | CLASS A COM | 81749D107 | 10,006,669 | 5,498,170 | SH | SOLE | 5,498,170 | 0 | 0 | ||
| Sionna Therapeutics, Inc. | COM | 829401108 | 17,596,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| Skye Bioscience, Inc. | COM | 83086J200 | 1,092,116 | 1,575,243 | SH | SOLE | 1,575,243 | 0 | 0 | ||
| Stoke Therapeutics, Inc. | COM | 86150R107 | 109,176,726 | 3,336,697 | SH | SOLE | 3,336,697 | 0 | 0 | ||
| Structure Therapeutics Inc. | SPONSORED ADS | 86366E106 | 76,883,831 | 1,432,529 | SH | SOLE | 1,432,529 | 0 | 0 | ||
| Summit Therapeutics Inc. | COM | 86627T108 | 477,697,090 | 32,786,348 | SH | SOLE | 32,786,348 | 0 | 0 | ||
| Surrozen, Inc. Warrants @ $172.50 8/11/2026 (15 FOR 1) | W EXP 8/11/2026 | 86889P117 | 13,750 | 833,333 | SH | SOLE | 833,333 | 0 | 0 | ||
| Tango Therapeutics, Inc. | COM | 87583X109 | 10,419,990 | 333,333 | SH | SOLE | 333,333 | 0 | 0 | ||
| Taysha Gene Therapies, Inc. | COM SHS | 877619106 | 27,272,388 | 4,004,756 | SH | SOLE | 4,004,756 | 0 | 0 | ||
| Tectonic Therapeutic, Inc. | COM | 878972108 | 20,892,713 | 607,788 | SH | SOLE | 607,788 | 0 | 0 | ||
| TScan Therapeutics, Inc. | COM | 89854M101 | 2,729,375 | 2,784,792 | SH | SOLE | 2,784,792 | 0 | 0 | ||
| Tyra Biosciences, Inc. | COM | 90240B106 | 338,788 | 10,607 | SH | SOLE | 10,607 | 0 | 0 | ||
| Verastem, Inc. | COM | 92337C203 | 9,547,471 | 2,499,338 | SH | SOLE | 2,499,338 | 0 | 0 | ||
| Viridian Therapeutics, Inc. | COM | 92790C104 | 43,776,169 | 2,383,025 | SH | SOLE | 2,383,025 | 0 | 0 | ||
| vTv Therapeutics, Inc. | CL A | 918385204 | 5,584,022 | 148,314 | SH | SOLE | 148,314 | 0 | 0 | ||
| Wave Life Sciences Ltd. | SHS | Y95308105 | 4,779,527 | 822,638 | SH | SOLE | 822,638 | 0 | 0 | ||
| Xencor, Inc. | COM | 98401F105 | 17,743,907 | 1,102,106 | SH | SOLE | 1,102,106 | 0 | 0 | ||
| Xenon Pharmaceuticals Inc. | COM | 98420N105 | 22,345,755 | 370,208 | SH | SOLE | 370,208 | 0 | 0 | ||
| Celcuity Inc. | Note 2.75% 8/1/2031 | 15102KAA8 | 69,158,687 | 30,750,000 | PRN | SOLE | 30,750,000 | 0 | 0 | ||